Paul Tudor Jones Medical Devices

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BSX Boston Scientific Corp	$130B	$27.6 Million 0.1% of portfolio	329,804	Q3 2024 Added 2,169.19%
ABT Abbott Laboratories	$201B	$12.8 Million 0.05% of portfolio	112,232	Q3 2024 Reduced 43.12%
GMED Globus Medical Inc	$6.43B	$11.9 Million 0.04% of portfolio	165,681	Q3 2024 Added 106.5%
EW Edwards Lifesciences Corp	$46.6B	$11 Million 0.04% of portfolio	167,146	Q3 2024 New
ZBH Zimmer Biomet Holdings, Inc.	$22.5B	$10.6 Million 0.04% of portfolio	98,616	Q3 2024 Added 478.66%
BRKR Bruker Corp	$8.63B	$9.09 Million 0.03% of portfolio	131,674	Q3 2024 Reduced 68.98%
LIVN Liva Nova PLC	$2.5B	$8.34 Million 0.03% of portfolio	158,746	Q3 2024 Added 45.4%
IART Integra Lifesciences Holdings Corp	$1.85B	$4.93 Million 0.02% of portfolio	271,418	Q3 2024 Reduced 3.52%
AORT Artivion, Inc.	$1.15B	$3.83 Million 0.01% of portfolio	143,964	Q3 2024 Added 109.24%
CNMD Conmed Corp	$2.14B	$3.54 Million 0.01% of portfolio	49,285	Q3 2024 Reduced 54.5%
BVS Bioventus Inc.	$657M	$3.07 Million 0.01% of portfolio	257,134	Q3 2024 Added 209.01%
INSP Inspire Medical Systems, Inc.	$5.36B	$2.18 Million 0.01% of portfolio	10,331	Q3 2024 Added 112.14%
OFIX Orthofix Medical Inc.	$347M	$2.08 Million 0.01% of portfolio	133,260	Q3 2024 Added 1.52%
SYK Stryker Corp	$140B	$1.81 Million 0.01% of portfolio	4,998	Q3 2024 New
TNDM Tandem Diabetes Care Inc	$2.38B	$1.73 Million 0.01% of portfolio	40,749	Q3 2024 Reduced 37.53%
AXGN Axogen, Inc.	$727M	$1.58 Million 0.01% of portfolio	112,352	Q3 2024 New
SIBN Si Bone, Inc.	$451M	$1.57 Million 0.01% of portfolio	112,384	Q3 2024 Reduced 22.01%
RXST Rx Sight, Inc.	$956M	$1.56 Million 0.01% of portfolio	31,469	Q3 2024 Reduced 62.14%
ZIMV Zim Vie Inc.	$361M	$1.54 Million 0.01% of portfolio	97,341	Q3 2024 Added 102.46%
GKOS Glaukos Corp	$7.06B	$1.28 Million 0.0% of portfolio	9,829	Q3 2024 New
AXNX Axonics, Inc.	$3.49B	$1.18 Million 0.0% of portfolio	16,965	Q3 2024 Reduced 36.83%
IRMD Iradimed Corp	$679M	$1.15 Million 0.0% of portfolio	22,869	Q3 2024 Added 352.94%
LUNG Pulmonx Corp	$233M	$1.13 Million 0.0% of portfolio	136,820	Q3 2024 Added 0.84%
TMCI Treace Medical Concepts, Inc.	$386M	$1.09 Million 0.0% of portfolio	187,101	Q3 2024 New
ATEC Alphatec Holdings, Inc.	$954M	$825,000 0.0% of portfolio	148,175	Q3 2024 New
NVRO Nevro Corp	$133M	$726,000 0.0% of portfolio	130,158	Q3 2024 Added 3.3%
ANIK Anika Therapeutics, Inc.	$237M	$724,000 0.0% of portfolio	29,342	Q3 2024 Added 2.5%
KIDS Orthopediatrics Corp	$518M	$649,000 0.0% of portfolio	23,960	Q3 2024 Added 6.07%
CVRX Cv Rx, Inc.	$257M	$559,000 0.0% of portfolio	63,482	Q3 2024 Added 7.75%
INGN Inogen Inc	$193M	$554,000 0.0% of portfolio	57,171	Q3 2024 Added 77.84%
NARI Inari Medical, Inc.	$2.86B	$549,000 0.0% of portfolio	13,338	Q3 2024 New
ARAY Accuray Inc	$175M	$543,000 0.0% of portfolio	301,761	Q3 2024 Added 63.47%
PACB Pacific Biosciences Of California, Inc.	$434M	$132,000 0.0% of portfolio	78,171	Q3 2024 New
OM Outset Medical, Inc.	$56.6M	$122,000 0.0% of portfolio	180,444	Q3 2024 Reduced 0.08%
SENS Senseonics Holdings, Inc.	$219M	$61,000 0.0% of portfolio	174,383	Q4 2022 Reduced 3.82%

Shares Options

Paul Tudor Jones

Paul Tudor Jones is the founder and CEO of Tudor Investment Corp, a successful investment firm that focuses on macro investing. Jones is known for his expertise in macro investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Paul Tudor Jones's portfolio

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account